Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
imx101 (1 trial)
rvsvdelta-zebov-gp (1 trial)
Hemorrhagic Fever, Ebola (Phase 1)
Hemorrhagic Fevers, Viral (Phase 1)
Primary Myelofibrosis (Phase 2)
Trials (2 total)
Trial APIs (2 total)